Time for Reflection re: Human Augmentation Neuromodulation.

REAL ID is Techno Enslavement. To be fully deployed by May 5, 2027:

The Real ID Act of 2005 is a United States federal law that standardized requirements for driver's licenses and identification cards issued by US states and territories in order to be accepted for accessing US government facilities, nuclear power plants, and for boarding airline flights in the United States.

The requirements include verification of the personal information presented when applying for the identification document, security features on the document, and electronic sharing of databases between states. The act also made modifications to US immigration law regarding asylum, border security, deportation, and specific work visas.

Enacted in response to the September 11 attacks, the provisions regarding identification documents were originally intended to take effect in 2008, but enforcement was repeatedly delayed due to widespread opposition and refusal by many state governments to implement them. Eventually states began to comply in 2012, and enforcement based on the issuing state or territory began from 2014 to 2018 depending on the facility. After numerous extensions, by 2020, all states were certified as compliant, and by 2024, all territories were certified. Enforcement based on the identification documents began on May 7, 2025, and is scheduled to be implemented in phases until complete enforcement begins on May 5, 2027.

CRISPR gene editing pronounced like "crisper"; an abbreviation for "clustered regularly interspaced short palindromic repeats") is a genetic engineering technique in molecular biology by which the genomes of living organisms may be modified. It is based on a simplified version of the bacterial CRISPR-Cas9 antiviral defense system. By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed or new ones added in vivo.

The technique is considered highly significant in biotechnology and medicine as it enables editing genomes in vivo and is precise, cost-effective, and efficient. It can be used in the creation of new medicines, agricultural products, and genetically modified organisms, or as a means of controlling pathogens and pests. It also offers potential in the treatment of inherited genetic diseases as well as diseases arising from somatic mutations such as cancer. However, its use in human germline genetic modification is highly controversial. The development of this technique earned Jennifer Doudna and Emmanuelle Charpentier the Nobel Prize in Chemistry in 2020. The third researcher group that shared the Kavli Prize for the same discovery, led by Virginijus Šikšnys, was not awarded the Nobel prize.

CRISPR Therapeutics AG is a Swiss American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom.

Bioinformatics is an interdisciplinary field of science that develops methods and software tools for understanding biological data, especially when the data sets are large and complex. Bioinformatics uses biology, chemistry, physics, computer science, data science, computer programming, information engineering, mathematics and statistics to analyze and interpret biological data. This process can sometimes be referred to as computational biology, however the distinction between the two terms is often disputed. To some, the term computational biology refers to building and using models of biological systems.

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. Neuromodulators typically bind to metabotropic, G-protein coupled receptors (GPCRs) to initiate a second messenger signaling cascade that induces a broad, long-lasting signal. This modulation can last for hundreds of milliseconds to several minutes. Some of the effects of neuromodulators include altering intrinsic firing activity, increasing or decreasing voltage-dependent currents, altering synaptic efficacy, increasing bursting activity and reconfiguring synaptic connectivity.

Network-centric warfare, also called network-centric operations or net-centric warfare, is a military doctrine or theory of war that aims to translate an information advantage, enabled partly by information technology, into a competitive advantage through the computer networking of dispersed forces. It was pioneered by the United States Department of Defense in the 1990s.